Review article · 2024 · Open access

Mitochondrial dysfunction: mechanisms and advances in therapy

Zong Yao, Hao Li, Peng Liao, Long Chen, Yao Pan, Yongqiang Zheng, Changqing Zhang, Delin Liu, Minghao Zheng, Junjie Gao

Signal Transduction and Targeted Therapy, 9(1), 124 · Published 14 May 2024 · DOI 10.1038/s41392-024-01839-8

Read the free full textCite this paper

In brief

“Mitochondrial dysfunction: mechanisms and advances in therapy” is a 2024 review article by Zong Yao and 9 co-authors, published in Signal Transduction and Targeted Therapy. OpenAlex counts 1,428 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Signal Transduction and Targeted Therapy.

Citations
1,428
Most cited in
2026 (693)
Field-weighted impact
49.75
References
454
Authors
10

Abstract

Mitochondria, with their intricate networks of functions and information processing, are pivotal in both health regulation and disease progression. Particularly, mitochondrial dysfunctions are identified in many common pathologies, including cardiovascular diseases, neurodegeneration, metabolic syndrome, and cancer. However, the multifaceted nature and elusive phenotypic threshold of mitochondrial dysfunction complicate our understanding of their contributions to diseases. Nonetheless, these complexities do not prevent mitochondria from being among the most important therapeutic targets. In recent years, strategies targeting mitochondrial dysfunction have continuously emerged and transitioned to clinical trials. Advanced intervention such as using healthy mitochondria to replenish or replace damaged mitochondria, has shown promise in preclinical trials of various diseases. Mitochondrial components, including mtDNA, mitochondria-located microRNA, and associated proteins can be potential therapeutic agents to augment mitochondrial function in immunometabolic diseases and tissue injuries. Here, we review current knowledge of mitochondrial pathophysiology in concrete examples of common diseases. We also summarize current strategies to treat mitochondrial dysfunction from the perspective of dietary supplements and targeted therapies, as well as the clinical translational situation of related pharmacology agents. Finally, this review discusses the innovations and potential applications of mitochondrial transplantation as an advanced and promising treatment.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024). Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 124. https://doi.org/10.1038/s41392-024-01839-8

MLA 9

Yao, Zong, et al. “Mitochondrial dysfunction: mechanisms and advances in therapy.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 124. https://doi.org/10.1038/s41392-024-01839-8.

Chicago

Yao, Zong, Hao Li, Peng Liao, Long Chen, Yao Pan, Yongqiang Zheng, Changqing Zhang, Delin Liu, Minghao Zheng, and Junjie Gao. 2024. “Mitochondrial dysfunction: mechanisms and advances in therapy.” Signal Transduction and Targeted Therapy 9 (1): 124. https://doi.org/10.1038/s41392-024-01839-8.

Harvard

Yao, Z. et al. (2024) ‘Mitochondrial dysfunction: mechanisms and advances in therapy’, Signal Transduction and Targeted Therapy, 9(1), p. 124. doi:10.1038/s41392-024-01839-8.

IEEE

Z. Yao et al., “Mitochondrial dysfunction: mechanisms and advances in therapy,” Signal Transduction and Targeted Therapy, vol. 9, no. 1, p. 124, 2024, doi: 10.1038/s41392-024-01839-8.

BibTeX

@article{yao2024mitochondrial,
  title     = {{Mitochondrial dysfunction: mechanisms and advances in therapy}},
  author    = {Yao, Zong and Li, Hao and Liao, Peng and Chen, Long and Pan, Yao and Zheng, Yongqiang and Zhang, Changqing and Liu, Delin and Zheng, Minghao and Gao, Junjie},
  journal   = {Signal Transduction and Targeted Therapy},
  year      = {2024},
  volume    = {9},
  number    = {1},
  pages     = {124},
  doi       = {10.1038/s41392-024-01839-8},
  url       = {https://doi.org/10.1038/s41392-024-01839-8}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201711
20248989
2025644644
2026693693

Its field-weighted citation impact is 49.75: it has been cited 49.75 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology

  • mitochondrial dysfunction
  • mitochondrial disease
  • mitochondrial transplantation
  • mitochondrial DNA
  • mitochondrial-targeted therapy
  • dietary supplements
  • tissue damage
  • cardiovascular disease

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024). Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 124. https://doi.org/10.1038/s41392-024-01839-8

How many times has this paper been cited?

1,428 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Signal Transduction and Targeted Therapy.

Who wrote this paper?

Zong Yao, Hao Li, Peng Liao, Long Chen, Yao Pan, Yongqiang Zheng, Changqing Zhang, Delin Liu, Minghao Zheng, Junjie Gao.

What is the DOI of this paper?

10.1038/s41392-024-01839-8. The permanent link is https://doi.org/10.1038/s41392-024-01839-8.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.